Copyright
©The Author(s) 2017.
World J Gastrointest Pathophysiol. Aug 15, 2017; 8(3): 117-126
Published online Aug 15, 2017. doi: 10.4291/wjgp.v8.i3.117
Published online Aug 15, 2017. doi: 10.4291/wjgp.v8.i3.117
Characteristic | Placebo(n = 13) | Probiotic(n = 15) |
Age (yr) | 21.8 ± 0.7 | 21.2 ± 0.5 |
Height (cm) | 167.9 ± 3.2 | 170.8 ± 2.7 |
Body mass (kg) | 74.2 ± 6.6 | 71.2 ± 3.1 |
Body mass index (kg/m2) | 25.9 ± 1.5 | 24.3 ± 0.9 |
Body fat (%) | 27.8 ± 4.1 | 25.2 ± 3.0 |
Fat mass (kg) | 21.0 ± 4.3 | 17.3 ± 2.4 |
Lean mass (kg) | 50.1 ± 3.8 | 50.0 ± 3.7 |
Bone mineral mass (kg) | 2.9 ± 0.2 | 2.9 ± 0.1 |
Resting energy expenditure (kcal/d) | 2243 ± 304 | 2071 ± 108 |
- Citation: McFarlin BK, Henning AL, Bowman EM, Gary MA, Carbajal KM. Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers. World J Gastrointest Pathophysiol 2017; 8(3): 117-126
- URL: https://www.wjgnet.com/2150-5330/full/v8/i3/117.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v8.i3.117